As this manuscript was under review, a paper was published showing the efficacy of a combinatorial treatment targeting PARP and hypoxia in a breast cancer PDX model82, demonstrating the potential for developing therapeutic strategies to overcome this resistance. The gene discussed is PARP1; the disease is breast cancer.